v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Jun. 30, 2026
Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net Loss $ (1,613,888) $ (2,311,037)
Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:    
Stock-based compensation 460,609 133,197
Depreciation and amortization 134,671 117,890
Amortization of Right-of-Use asset 16,057 15,722
Unrealized loss on change in fair value of derivatives 320,404
Loss on disposal of fixed assets 149,125
Amortization of debt discount 66,259
Common stock issued for services 160,000 40,420
Changes in Operating Assets and Liabilities    
Prepaid expenses and other current assets (13,330) 56,076
Accounts receivable 17,051 34,625
Inventory 87,032 (205,838)
Accounts payable and accrued expenses (202,933) (87,996)
Lease liabilities (16,057) (15,722)
Accrued interest on notes payable 5,009 53,120
Net Cash (Used In) Operating Activities (965,779) (1,633,755)
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of equipment (12,370)
Net Cash (Used in) Investing Activities (12,370)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds received from common stock subscription receivable 600,000
Proceeds from issuance of common stock 150,000
Proceeds received from preferred stock subscription receivable 4,400,000
Proceeds from the issuance of convertible debentures 160,000
Proceeds from the exercise of warrants 140,000
Proceeds from the issuance of notes payable 150,000 12,000
Repayments of notes payable (2,090)
Net Cash Provided by Financing Activities 900,000 4,709,910
Net (decrease)/increase in Cash (78,149) 3,076,155
Cash at Beginning of Period 200,782 227,689
Cash at End of Period 122,633 3,303,844
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Interest 2,635
Stock granted for consulting services 161,000
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING AND INVESTING ACTIVITIES    
(Decrease) increase to operating lease right of use asset and operating lease liability (859,504)
Vesting of restricted stock units 150
Dividends declared on Series B preferred stock 125,000
Convertible debentures and accrued interest converted to common stock 301,558
Common stock issued for prepaid consulting fees $ 160,000